Loading...
Treace Medical Concepts, Inc.
TMCI•NASDAQ
Healthcare
Medical - Devices
$5.70
$-0.09(-1.55%)
Treace Medical Concepts, Inc. (TMCI) Financial Performance & Income Statement Overview
Review Treace Medical Concepts, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
11.89%
↑ 11.89%
Operating Income Growth
-8.28%
↓ 8.28%
Net Income Growth
-12.55%
↓ 12.55%
Operating Cash Flow Growth
-7.50%
↓ 7.50%
Operating Margin
-24.81%
↓ 24.81%
Gross Margin
80.25%
↑ 80.25%
Net Profit Margin
-25.13%
↓ 25.13%
ROE
-48.69%
↓ 48.69%
ROIC
-30.29%
↓ 30.29%
Treace Medical Concepts, Inc. (TMCI) Income Statement & Financial Overview
Review Treace Medical Concepts, Inc.'s (TMCI) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $68.71M | $45.09M | $44.45M | $51.11M |
| Cost of Revenue | $13.23M | $8.95M | $8.78M | $10.13M |
| Gross Profit | $55.48M | $36.13M | $35.67M | $40.98M |
| Gross Profit Ratio | $0.81 | $0.80 | $0.80 | $0.80 |
| R&D Expenses | $5.21M | $4.96M | $5.16M | $5.26M |
| SG&A Expenses | $50.47M | $46.30M | $51.90M | $54.69M |
| Operating Expenses | $55.68M | $51.27M | $57.06M | $59.95M |
| Total Costs & Expenses | $68.91M | $60.22M | $65.84M | $70.08M |
| Interest Income | $899000.00 | $1.07M | $1.38M | $1.53M |
| Interest Expense | $1.31M | $1.31M | $1.31M | $1.32M |
| Depreciation & Amortization | $2.24M | $2.16M | $2.12M | $1.91M |
| EBITDA | $3.05M | -$11.89M | -$17.78M | -$15.45M |
| EBITDA Ratio | $0.04 | -$0.26 | -$0.40 | -$0.30 |
| Operating Income | -$204000.00 | -$15.13M | -$21.38M | -$18.97M |
| Operating Income Ratio | -$0.003 | -$0.34 | -$0.48 | -$0.37 |
| Other Income/Expenses (Net) | -$297000.00 | -$226000.00 | $176000.00 | $292000.00 |
| Income Before Tax | -$501000.00 | -$15.36M | -$21.21M | -$18.68M |
| Income Before Tax Ratio | -$0.007 | -$0.34 | -$0.48 | -$0.37 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $1.87M |
| Net Income | -$501000.00 | -$15.36M | -$21.21M | -$18.68M |
| Net Income Ratio | -$0.007 | -$0.34 | -$0.48 | -$0.37 |
| EPS | -$0.008 | -$0.25 | -$0.34 | -$0.30 |
| Diluted EPS | -$0.008 | -$0.25 | -$0.34 | -$0.30 |
| Weighted Avg Shares Outstanding | $62.34M | $62.23M | $62.08M | $61.79M |
| Weighted Avg Shares Outstanding (Diluted) | $62.34M | $62.23M | $62.08M | $61.79M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan